Proterra Inc.
PTRAQ
OTC PK
| Weiss Ratings | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.31 | |||
| Price History | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.38% | |||
| 30-Day Total Return | 0.38% | |||
| 60-Day Total Return | 0.38% | |||
| 90-Day Total Return | 0.38% | |||
| Year to Date Total Return | 0.38% | |||
| 1-Year Total Return | 0.38% | |||
| 2-Year Total Return | -99.55% | |||
| 3-Year Total Return | -99.82% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -10.78% | |||
| 52-Week Low % Change | 26.79% | |||
| Price | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Mar 13, 2025 | |||
| Valuation | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | -- | |||
| Dividends and Shares | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 689 8855 | |||
| Address | 504 Pennsylvania Avenue Greer, SC 29652 | |||
| Website | www.proterra.com | |||
| Country | United States | |||
| Year Founded | 2004 | |||
| Profitability | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -77.64% | |||
| Profit Margin | -105.84% | |||
| Management Effectiveness | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.15% | |||
| Return on Equity | -- | |||
| Income Statement | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 331.39M | |||
| Total Revenue (TTM) | 331.39M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -50.64M | |||
| EBITDA (TTM) | -239.23M | |||
| EBIT (TTM) | -257.29M | |||
| Net Income (TTM) | -350.75M | |||
| Net Income Avl. to Common (TTM) | -350.75M | |||
| Total Revenue Growth (Q YOY) | -10.47% | |||
| Earnings Growth (Q YOY) | 108.02% | |||
| EPS Diluted (TTM) | -1.56 | |||
| EPS Diluted Growth (Q YOY) | 104.44% | |||
| Balance Sheet | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 130.71M | |||
| Cash Per Share (Q) | $0.57 | |||
| Total Current Assets (Q) | 538.96M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 275.21M | |||
| Current Ratio (Q) | 2.478 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 217.47M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 275.21M | |||
| Cash Flow | PTRAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 304.41M | |||
| Cash from Financing (TTM) | 50.00K | |||
| Net Change in Cash (TTM) | 66.19M | |||
| Levered Free Cash Flow (TTM) | -334.60M | |||
| Cash from Operations (TTM) | -238.28M | |||
